Ohgaki K - Search Results

1

[A case report of serous cystadenoma located in pancreatic tail].

Kaganoi J, Hori T, Nagai T, Ohgaki K, Takano K, Kakita T, Yamamoto T. Kaganoi J, et al. Among authors: ohgaki k. Nihon Geka Hokan. 1992 Mar 1;61(2):205-9. Nihon Geka Hokan. 1992. PMID: 1530389 Japanese.

2

[Treatment with cis-platinum (CDDP) for pre-treated local recurrence from breast cancer; effectiveness of intratumoral injection of CDDP].

Hori T, Ohgaki K. Hori T, et al. Among authors: ohgaki k. Gan To Kagaku Ryoho. 1992 Apr;19(4):557-9. Gan To Kagaku Ryoho. 1992. PMID: 1558407 Japanese. No abstract available.

3

[Tuberculosis of the breast].

Ohgaki K, Hori T. Ohgaki K, et al. Nihon Rinsho. 1998 Dec;56(12):3126-8. Nihon Rinsho. 1998. PMID: 9883624 Review. Japanese.

4

[Two patients with StageIV gastric cancer responding to combination therapy with S-1 and low-dose CDDP after reduction surgery].

Sugie T, Nagai T, Ohgaki K. Sugie T, et al. Among authors: ohgaki k. Gan To Kagaku Ryoho. 2007 May;34(5):765-8. Gan To Kagaku Ryoho. 2007. PMID: 17496454 Japanese.

5

[A case of HER2-positive metastatic breast cancer responding to trastuzumab plus gemcitabine combination therapy].

Sugie T, Nagai T, Ohgaki K. Sugie T, et al. Among authors: ohgaki k. Gan To Kagaku Ryoho. 2008 Apr;35(4):683-6. Gan To Kagaku Ryoho. 2008. PMID: 18408445 Japanese.

6

Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusion.

Hori T, Mise K, Kan N, Okino T, Satoh K, Yamasaki S, Teramura Y, Harada T, Ohgaki K, Kodama H, et al. Hori T, et al. Among authors: ohgaki k. Biotherapy. 1992;5(1):21-9. doi: 10.1007/BF02194783. Biotherapy. 1992. PMID: 1389900

7

Factors influencing the response and survival of patients with liver metastases from breast cancer receiving OK-432-combined adoptive immunotherapy.

Yamasaki S, Okino T, Kan N, Satoh K, Mise K, Teramura Y, Harada T, Kodama H, Hori T, Ohgaki K, et al. Yamasaki S, et al. Among authors: ohgaki k. J Cancer Res Clin Oncol. 1992;118(2):157-62. doi: 10.1007/BF01187506. J Cancer Res Clin Oncol. 1992. PMID: 1735736

8

The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancers.

Satoh K, Kan N, Okino T, Mise K, Yamasaki S, Harada T, Hori T, Ohgaki K, Tobe T. Satoh K, et al. Among authors: ohgaki k. Biotherapy. 1993;6(1):41-9. doi: 10.1007/BF01877385. Biotherapy. 1993. PMID: 8507544

9

[Clinical therapeutic effect of adoptive immunotherapy using IL-2-cultured autologous lymphocytes].

Kan N, Okino T, Nakanishi M, Satou K, Mise K, Ohgaki K, Hori T, Kodama H, Tobe T. Kan N, et al. Among authors: ohgaki k. Hum Cell. 1988 Sep;1(3):289-96. Hum Cell. 1988. PMID: 2979206 Japanese.

10

The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from breast cancer.

Okino T, Kan N, Nakanishi M, Satoh K, Mise K, Teramura Y, Yamasaki S, Hori T, Kodama H, Ohgaki K, et al. Okino T, et al. Among authors: ohgaki k. J Cancer Res Clin Oncol. 1990;116(2):197-202. doi: 10.1007/BF01612677. J Cancer Res Clin Oncol. 1990. PMID: 2324164

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters